SCO1
Basic information
Region (hg38): 17:10672474-10698375
Previous symbols: [ "SCOD1" ]
Links
Phenotypes
GenCC
Source:
- cytochrome-c oxidase deficiency disease (Definitive), mode of inheritance: AR
- mitochondrial complex 4 deficiency, nuclear type 4 (Strong), mode of inheritance: AR
- mitochondrial complex 4 deficiency, nuclear type 4 (Moderate), mode of inheritance: AR
- mitochondrial disease (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Mitochondrial complex IV deficiency, nuclear type 4 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing; Attention deficit-hyperactivity disorder, susceptibility to refers to a susceptibility locus and/or evidence or clinical applicability unclear | Biochemical; Cardiovascular; Gastrointestinal; Musculoskeletal; Neurologic | 11013136; 22231385 |
ClinVar
This is a list of variants' phenotypes submitted to
- Mitochondrial complex IV deficiency, nuclear type 1 (1 variants)
- not provided (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SCO1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 30 | 36 | ||||
missense | 62 | 67 | ||||
nonsense | 2 | |||||
start loss | 2 | |||||
frameshift | 5 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 5 | 4 | 9 | |||
non coding | 12 | 21 | 27 | 60 | ||
Total | 2 | 5 | 86 | 54 | 27 |
Highest pathogenic variant AF is 0.0000197
Variants in SCO1
This is a list of pathogenic ClinVar variants found in the SCO1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-10680388-T-C | Mitochondrial complex IV deficiency, nuclear type 1 • Leigh syndrome | Uncertain significance (Jan 12, 2018) | ||
17-10680397-G-C | Mitochondrial complex IV deficiency, nuclear type 1 • Leigh syndrome | Benign (Jan 12, 2018) | ||
17-10680517-GT-G | Leigh syndrome • Mitochondrial complex IV deficiency, nuclear type 1 | Uncertain significance (Jun 14, 2016) | ||
17-10680525-T-C | Leigh syndrome • Mitochondrial complex IV deficiency, nuclear type 1 | Uncertain significance (Jan 13, 2018) | ||
17-10680593-A-G | Mitochondrial complex IV deficiency, nuclear type 1 • Leigh syndrome | Uncertain significance (Jan 13, 2018) | ||
17-10680716-T-C | Leigh syndrome • Mitochondrial complex IV deficiency, nuclear type 1 | Uncertain significance (Jan 13, 2018) | ||
17-10680770-G-C | Mitochondrial complex IV deficiency, nuclear type 1 • Leigh syndrome | Uncertain significance (Jan 13, 2018) | ||
17-10680793-G-A | Leigh syndrome • Mitochondrial complex IV deficiency, nuclear type 1 | Uncertain significance (Jan 13, 2018) | ||
17-10680799-T-T | Leigh syndrome • Mitochondrial complex IV deficiency, nuclear type 1 | Benign (Jun 14, 2018) | ||
17-10680809-G-A | Leigh syndrome • Mitochondrial complex IV deficiency, nuclear type 1 | Benign/Likely benign (Jul 09, 2018) | ||
17-10680834-G-A | Mitochondrial complex IV deficiency, nuclear type 1 • Leigh syndrome | Uncertain significance (Jan 13, 2018) | ||
17-10680847-A-G | Leigh syndrome • Mitochondrial complex IV deficiency, nuclear type 1 | Benign/Likely benign (Jul 09, 2018) | ||
17-10680849-A-T | Leigh syndrome | Likely benign (Jan 13, 2018) | ||
17-10680992-T-C | Mitochondrial complex IV deficiency, nuclear type 1 • Leigh syndrome | Uncertain significance (Jan 13, 2018) | ||
17-10681038-T-C | Mitochondrial complex IV deficiency, nuclear type 1 • Leigh syndrome | Uncertain significance (Jan 13, 2018) | ||
17-10681039-T-C | Mitochondrial complex IV deficiency, nuclear type 1 • Leigh syndrome | Uncertain significance (Jan 12, 2018) | ||
17-10681058-T-G | Mitochondrial complex IV deficiency, nuclear type 1 • Leigh syndrome | Uncertain significance (Jan 13, 2018) | ||
17-10681101-C-T | not specified | Likely benign (May 01, 2017) | ||
17-10681144-A-T | not specified • Mitochondrial complex 4 deficiency, nuclear type 4 • Inborn genetic diseases | Uncertain significance (May 15, 2024) | ||
17-10681157-T-C | Mitochondrial complex IV deficiency, nuclear type 1 • Leigh syndrome • Mitochondrial complex 4 deficiency, nuclear type 4 | Conflicting classifications of pathogenicity (Aug 10, 2023) | ||
17-10681175-C-T | Uncertain significance (Aug 22, 2022) | |||
17-10681177-T-C | Inborn genetic diseases | Uncertain significance (Aug 13, 2021) | ||
17-10681185-G-C | Inborn genetic diseases | Uncertain significance (May 12, 2024) | ||
17-10681190-G-A | Uncertain significance (Nov 20, 2023) | |||
17-10681201-T-C | Inborn genetic diseases | Uncertain significance (Jun 05, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SCO1 | protein_coding | protein_coding | ENST00000255390 | 6 | 18039 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000223 | 0.923 | 125713 | 0 | 35 | 125748 | 0.000139 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.196 | 177 | 170 | 1.04 | 0.00000849 | 1920 |
Missense in Polyphen | 41 | 55.787 | 0.73494 | 677 | ||
Synonymous | -0.536 | 73 | 67.4 | 1.08 | 0.00000359 | 603 |
Loss of Function | 1.59 | 8 | 14.6 | 0.549 | 7.09e-7 | 175 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000119 | 0.000119 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000229 | 0.000229 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000196 | 0.000196 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Copper metallochaperone essential for the maturation of cytochrome c oxidase subunit II (MT-CO2/COX2). Not required for the synthesis of MT-CO2/COX2 but plays a crucial role in stabilizing MT-CO2/COX2 during its subsequent maturation. Involved in transporting copper to the Cu(A) site on MT-CO2/COX2 (PubMed:15659396, PubMed:16735468, PubMed:17189203, PubMed:19336478, PubMed:15229189). Plays an important role in the regulation of copper homeostasis by controlling the abundance and cell membrane localization of copper transporter CTR1 (By similarity). {ECO:0000250|UniProtKB:Q5SUC9, ECO:0000269|PubMed:15229189, ECO:0000269|PubMed:15659396, ECO:0000269|PubMed:16735468, ECO:0000269|PubMed:17189203, ECO:0000269|PubMed:19336478}.;
- Pathway
- Electron Transport Chain;Copper homeostasis;Gene expression (Transcription);Generic Transcription Pathway;RNA Polymerase II Transcription;Respiratory electron transport;The citric acid (TCA) cycle and respiratory electron transport;Metabolism;TP53 Regulates Metabolic Genes;Transcriptional Regulation by TP53;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.
(Consensus)
Recessive Scores
- pRec
- 0.144
Intolerance Scores
- loftool
- 0.208
- rvis_EVS
- -0.18
- rvis_percentile_EVS
- 39.95
Haploinsufficiency Scores
- pHI
- 0.0396
- hipred
- Y
- hipred_score
- 0.638
- ghis
- 0.583
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.751
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Sco1
- Phenotype
- growth/size/body region phenotype; cellular phenotype; homeostasis/metabolism phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; liver/biliary system phenotype; immune system phenotype;
Gene ontology
- Biological process
- generation of precursor metabolites and energy;copper ion transport;cellular copper ion homeostasis;respiratory chain complex IV assembly;mitochondrial respiratory chain complex IV assembly;negative regulation of proteasomal protein catabolic process
- Cellular component
- mitochondrion;myofibril;integral component of mitochondrial inner membrane;host cell mitochondrial intermembrane space
- Molecular function
- copper ion binding;protein binding